Kissei Pharmaceutical Co., Ltd.
Clinical trials sponsored by Kissei Pharmaceutical Co., Ltd., explained in plain language.
-
New drug trial aims to ease debilitating endometriosis pain
Disease control OngoingThis study is testing whether a new drug called KLH-2109 is as effective as a standard medication (leuprorelin acetate) at reducing pelvic pain in people with endometriosis. It involves 288 premenopausal women with confirmed endometriosis. The main goal is to see if the new drug …
Phase: PHASE3 • Sponsor: Kissei Pharmaceutical Co., Ltd. • Aim: Disease control
Last updated Apr 02, 2026 02:11 UTC
-
New hope for controlling advanced Parkinson's symptoms
Disease control OngoingThis trial is testing a new daily medicine called KDT-3594 for people with advanced Parkinson's disease who are already taking levodopa. The main goal is to see if it can better control movement symptoms and reduce the amount of time when medication wears off ('off' time). About …
Phase: PHASE2 • Sponsor: Kissei Pharmaceutical Co., Ltd. • Aim: Disease control
Last updated Mar 24, 2026 12:01 UTC